Philip A. Patston

679 total citations
29 papers, 525 citations indexed

About

Philip A. Patston is a scholar working on Hematology, Cancer Research and Genetics. According to data from OpenAlex, Philip A. Patston has authored 29 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 13 papers in Cancer Research and 9 papers in Genetics. Recurrent topics in Philip A. Patston's work include Protease and Inhibitor Mechanisms (13 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Philip A. Patston is often cited by papers focused on Protease and Inhibitor Mechanisms (13 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Philip A. Patston collaborates with scholars based in United States, Switzerland and Sweden. Philip A. Patston's co-authors include Peter G.W. Gettins, M Schapira, James A. Huntington, Philip J. Randle, Hasmukh R. Fatania, Ivana Simonović, John M. Collins, Jeremy J. Mao, G. William Knight and Sriram Ravindran and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

In The Last Decade

Philip A. Patston

28 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip A. Patston United States 15 170 139 121 85 75 29 525
P Vaughan United States 11 257 1.5× 128 0.9× 198 1.6× 60 0.7× 34 0.5× 15 716
Huihui Zhao China 15 235 1.4× 110 0.8× 97 0.8× 30 0.4× 24 0.3× 49 571
Ricardo Sánchez Spain 13 300 1.8× 48 0.3× 111 0.9× 25 0.3× 28 0.4× 37 541
Reema Patel United States 15 80 0.5× 40 0.3× 102 0.8× 33 0.4× 22 0.3× 43 625
Levi Makala United States 13 335 2.0× 26 0.2× 73 0.6× 102 1.2× 98 1.3× 18 611
Jung‐Sook Ha South Korea 12 207 1.2× 28 0.2× 80 0.7× 89 1.0× 19 0.3× 45 433
Kulsoom Ghias Pakistan 14 315 1.9× 103 0.7× 68 0.6× 31 0.4× 15 0.2× 54 872
Amanda Harvey United Kingdom 17 615 3.6× 126 0.9× 34 0.3× 23 0.3× 78 1.0× 43 1.0k
Young-Sook Lee South Korea 11 263 1.5× 25 0.2× 77 0.6× 24 0.3× 31 0.4× 17 543
Elizabeth Thomas Australia 12 184 1.1× 41 0.3× 71 0.6× 43 0.5× 21 0.3× 38 757

Countries citing papers authored by Philip A. Patston

Since Specialization
Citations

This map shows the geographic impact of Philip A. Patston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Patston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Patston more than expected).

Fields of papers citing papers by Philip A. Patston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. Patston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Patston. The network helps show where Philip A. Patston may publish in the future.

Co-authorship network of co-authors of Philip A. Patston

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. Patston. A scholar is included among the top collaborators of Philip A. Patston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. Patston. Philip A. Patston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Briggs, Charlotte L., et al.. (2013). Fitting Form to Function: Reorganization of Faculty Roles for a New Dental Curriculum and Its Governance. Journal of Dental Education. 77(1). 4–16. 7 indexed citations
2.
Ravindran, Sriram, M Schapira, & Philip A. Patston. (2012). Modulation of C1-Inhibitor and Plasma Kallikrein Activities by Type IV Collagen. International Journal of Biomaterials. 2012. 1–5. 2 indexed citations
3.
Patston, Philip A., et al.. (2010). Maximising the potential of part‐time clinical teachers. The Clinical Teacher. 7(4). 247–250. 11 indexed citations
4.
Patston, Philip A.. (2007). Constructive Functional Diversity: A new paradigm beyond disability and impairment. Disability and Rehabilitation. 29(20-21). 1625–1633. 32 indexed citations
5.
Ravindran, Sriram, Thomas E. Grys, Rodney A. Welch, M Schapira, & Philip A. Patston. (2004). Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor. Thrombosis and Haemostasis. 92(12). 1277–1283. 22 indexed citations
6.
Collins, John M., et al.. (2004). Expression of matrix metalloproteinase genes in the rat intramembranous bone during postnatal growth and upon mechanical stresses. Journal of Biomechanics. 38(3). 485–492. 30 indexed citations
7.
Patston, Philip A.. (2003). Serpin–ligand interactions. Methods. 32(2). 93–109. 17 indexed citations
8.
Patston, Philip A., et al.. (2002). α1‐Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1. Protein Science. 11(9). 2230–2236. 16 indexed citations
9.
Patston, Philip A., et al.. (2002). Release and Degradation of Angiotensin I and Angiotensin II from Angiotensinogen by Neutrophil Serine Proteinases. Archives of Biochemistry and Biophysics. 397(1). 77–83. 39 indexed citations
10.
Gettins, Peter G.W., et al.. (2000). Linkage between the Hormone Binding Site and the Reactive Center Loop of Thyroxine Binding Globulin. Archives of Biochemistry and Biophysics. 384(1). 31–36. 18 indexed citations
11.
Hauert, J, Philip A. Patston, & M Schapira. (2000). C1 Inhibitor Cross-linking by Tissue Transglutaminase. Journal of Biological Chemistry. 275(19). 14558–14562. 14 indexed citations
12.
Simonović, Ivana & Philip A. Patston. (2000). The native metastable fold of C1-inhibitor is stabilized by disulfide bonds. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1481(1). 97–102. 13 indexed citations
13.
Patston, Philip A., et al.. (1998). Influence of the P5 Residue on α1-Proteinase Inhibitor Mechanism. Journal of Biological Chemistry. 273(8). 4569–4573. 19 indexed citations
14.
Olson, Steven T., Richard Swanson, Philip A. Patston, & Ingemar Björk. (1997). Apparent Formation of Sodium Dodecyl Sulfate-stable Complexes between Serpins and 3,4-Dichloroisocoumarin-inactivated Proteinases Is Due to Regeneration of Active Proteinase from the Inactivated Enzyme. Journal of Biological Chemistry. 272(20). 13338–13342. 7 indexed citations
15.
Patston, Philip A., et al.. (1997). Reactivation of C1-Inhibitor Polymers by Denaturation and Gel-Filtration Chromatography. Analytical Biochemistry. 248(2). 228–233. 10 indexed citations
16.
Patston, Philip A. & M Schapira. (1997). Regulation of C1-Inhibitor Function by Binding to Type IV Collagen and Heparin. Biochemical and Biophysical Research Communications. 230(3). 597–601. 19 indexed citations
17.
Patston, Philip A. & Peter G.W. Gettins. (1996). Significance of secondary structure predictions on the reactive center loop region of seprins: a model for the folding of serpins into a metastable state. FEBS Letters. 383(1-2). 87–92. 20 indexed citations
18.
Huntington, James A., Peter G.W. Gettins, & Philip A. Patston. (1995). S‐ovalbumin, an ovalbumin conformer with properties analogous to those of loop‐inserted serpins. Protein Science. 4(4). 613–621. 42 indexed citations
19.
Patston, Philip A., Peter G.W. Gettins, & M Schapira. (1994). Serpins Are Suicide Substrates: Implications for the Regulation of Proteolytic Pathways. Seminars in Thrombosis and Hemostasis. 20(4). 410–416. 22 indexed citations
20.
Schapira, M & Philip A. Patston. (1991). Serine protease inhibitors (serpins). Trends in Cardiovascular Medicine. 1(4). 146–151. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026